Usana Health Sciences Inc
USNA· NYSE
Usana Health Sciences Inc
- Last sale
- Oct 2, 2026 · +2.82%
- Market cap
- $273.27M
- 18.48M shares
- Filings
- 1,037
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2026-01-03 | $925,257,000 | reported | |
| FY 2023 | 2024-12-28 | $854,503,000 | reported | |
| FY 2022 | 2023-12-30 | $921,010,000 | reported | |
| FY 2021 | 2022-12-31 | $998,601,000 | reported | |
| FY 2020 | 2021-01-02 | $1,134,644,000 | reported | |
| FY 2019 | 2019-12-28 | $1,060,902,000 | reported | |
| FY 2018 | 2018-12-29 | $1,189,248,000 | reported | |
| FY 2017 | 2017-12-30 | $1,047,265,000 | reported | |
| FY 2016 | 2016-12-31 | $1,006,083,000 | reported | |
| FY 2015 | 2016-01-02 | $918,499,000 | reported | |
| FY 2014 | 2015-01-03 | $790,471,000 | reported |
Usana Health Sciences Inc · CIK 896264 · Engraved from SEC EDGAR
